Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02411357 · ClinicalTrials.gov registry record · NA

Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II

A NA study of Opioid Dependence and Contraceptive Usage, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
138
Enrollment target
1
Study location

NCT02411357 is a NA study of Opioid Dependence and Contraceptive Usage that has completed, run by University of Vermont. The registered enrollment target is 138 participants, below the 154-participant average among 29 other Opioid Dependence trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02411357, a NA study of Opioid Dependence and Contraceptive Usage, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
138 participants
Enrollment target
1
Study location

Study Summary

Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to further test a novel contraceptive management program to increase use of more effective contraceptives among opioid-maintained women at risk of unintended pregnancy.

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Incentives
  • BEHAVIORAL WHO contraception protocol

Study Locations (1)

Vermont

  • Vermont Center on Behavior and Health - Burlington

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2015-05-05
Est. Completion 2019-09-09
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT02411357

The ClinicalTrials.gov registry entry for NCT02411357 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 29 other Opioid Dependence trials with a reported enrollment target (10% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Dependence appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.

NCT02411357 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.

Frequently Asked Questions

What is clinical trial NCT02411357 about?

NCT02411357 is a clinical study titled "Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II". Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to further test a novel contraceptive management prog...

What is the current status of trial NCT02411357?

This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2015-05-05. Estimated completion is 2019-09-09.

What conditions does trial NCT02411357 study?

This clinical trial studies the following conditions: Opioid Dependence, Contraceptive Usage.

What interventions are being tested in trial NCT02411357?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Incentives (BEHAVIORAL), WHO contraception protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT02411357?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02411357 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.